154 related articles for article (PubMed ID: 33109107)
1. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1.
Meng Y; Hu X; Li S; Zeng X; Qiu L; Wei M; Wang Z; Han J
BMC Cancer; 2020 Oct; 20(1):1028. PubMed ID: 33109107
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways.
Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS
PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276
[TBL] [Abstract][Full Text] [Related]
3. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.
Cao YL; Liu DJ; Zhang HG
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4427-4430. PubMed ID: 30058674
[TBL] [Abstract][Full Text] [Related]
4. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
5. Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.
Zhang X; Fang J; Chen S; Wang W; Meng S; Liu B
Cancer Med; 2019 Sep; 8(12):5716-5734. PubMed ID: 31389670
[TBL] [Abstract][Full Text] [Related]
6. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
[TBL] [Abstract][Full Text] [Related]
8. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
Zhang X; Jin K; Luo JD; Liu B; Xie LP
Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
[TBL] [Abstract][Full Text] [Related]
10. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
Hu CY; You P; Zhang J; Zhang H; Jiang N
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
[TBL] [Abstract][Full Text] [Related]
11. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
Yang ZG; Ma XD; He ZH; Guo YX
Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
[TBL] [Abstract][Full Text] [Related]
12. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
15. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer.
Ling Z; Liu D; Zhang G; Liang Q; Xiang P; Xu Y; Han C; Tao T
Oncol Rep; 2017 Sep; 38(3):1621-1628. PubMed ID: 29094170
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
Liang X; Li H; Fu D; Chong T; Wang Z; Li Z
Biochem Biophys Res Commun; 2016 Nov; 480(2):208-214. PubMed ID: 27746178
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
18. miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
Ma Y; Zhang H; He X; Song H; Qiang Y; Li Y; Gao J; Wang Z
Tumour Biol; 2015 Nov; 36(11):8389-98. PubMed ID: 26018509
[TBL] [Abstract][Full Text] [Related]
19. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
20. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
Zheng C; Guo K; Chen B; Wen Y; Xu Y
Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
